We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

A recent study on psoriatic arthritis care revealed that patients and clinicians agree on key aspects of disease management ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Impact of Disease questionnaire (PsAID-12) scores were associated with treatment escalation, physicians primarily relied on ...

The Waterloo Road actor appeared on This Morning and revealed he is turning to lifestyle changes to help manage his condition ...

A new study finds no significant differences in cardiovascular and thromboembolic risks among biologics for psoriasis or ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

LAPIX plans to submit a third IND for LPX-TI641 in the first quarter of 2025 with the dermatology division at the US-FDA.

The "Psoriatic Arthritis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, and global and ...

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.